KARGER.CH : www.karger.ch - 134 in TOP 100 MEDICAL SITES. Rating: 37300.

Description: Karger is a medical publisher, scientific publisher and biomedical publisher of print journals, electronic online journals and books in all medical specialities, including immunology, genetics, oncology, nephrology, neurology, cellular and molecular biology.

Most popular searches: Gynecology and Obstetrics, www.karger.com, wwwkarger.ch, Medical Subspecialties, Endocrinology, Media Data, wwwkarger.ch, www.karger.ch, www.karegr.ch, Cellular and Molecular Biology, www.karer.ch, www.akrger.ch, www.kager.ch, Reprints, www.kargr.ch, Peer-Reviewed, Psychology, Surgery, Geriatrics and G, Electronic Journals, Medicine, ww.wkarger.ch, www.karger.h, www.kargerc.h, wwwk.arger.ch, Oncology, ww.karger.ch, Pharmacology, Genetics, www.kagrer.ch, www.arger.ch, ww.karger.ch, Dermatology, www.krger.ch, www.karger.c, Books, Specialty Journals, Neurology, Hematology, www.kargerch, www.karge.rch, Cardiovascular System, Nephrology, Gastroenterology, Biochemistry, Otorhinolaryngology, www.karger.hc, www.krager.ch, www.kargre.ch, www.karge.ch, www.karger.ch, Publishers

Gilead Sciences: Expect Share Price to Move Up
Gilead Sciences (GILD) is a good bio-technology companies with their strong franchise in HIV, a growing franchise in Hepatitis and potential in cardio-vascular therapies. Many think of Gilead as the provider of Tamiflu, a therapy for influenza. However, Tamiflu is a small part of the story and it has limited impact on the company’s prospects. The strength of the company lies with its antiviral franchise, which experienced sales increase of 26 percent to $1.41 billion in the second quarter of 2009 due primarily to Truvada, which grew 18 percent and Atripla, which saw 60 percent sales increase. Tamiflu, sold through a partnership with Hoffmann-La Roche Ltd (Roche (RHHBY.PK)) provided royalties of $51.9 million in the second quarter of 2009. Europe is generating the best growth for Gilead’s HIV products.Complete Story »
seekingalpha.com

Antiabortion Measure Turned Away
The Senate Finance Committee turned back Republican-led efforts to tighten abortion restrictions in health legislation, and the Senate's top Democrat said he wants to bring a sweeping bill to the floor in two weeks.
online.wsj.com

Thermo Fisher Scientific, Inc. Q3 2009 Earnings Call Transcript
Thermo Fisher Scientific, Inc. (TMO)Q3 2009 Earnings CallOctober 22, 2009 8:30 am ETComplete Story »
seekingalpha.com

Health Insurer Aims to Alter Fee Model
Blue Cross Blue Shield is expected to announce a deal that will mark one of the country's largest experiments in fundamentally changing the way doctors and hospitals are paid.
online.wsj.com

Inverness Medical Innovations Offers to Acquire Standard Diagnostics (PR Newswire)
Inverness Medical Innovations, Inc. , a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has commenced a cash tender offer to acquire a majority equity interest in Standard Diagnostics , a leading innovator of rapid diagnostics in Korea. Â
us.rd.yahoo.com